A role for TRPC6 channels in the pathophysiology of acquired glomerular disorders can be inferred when some aspect of their expression or function is dysregulated in a human disease or in an animal disease model, and when inhibition or deletion of TRPC6 channels ameliorates either the disease process or some physiological index of glomerular filtration. This evidence concerns the gene TRPC6 and glomerular disorder.